Clover Health Investments (NASDAQ:CLOV) Announces Quarterly Earnings Results

Clover Health Investments (NASDAQ:CLOV) posted its earnings results on Monday. The company reported $0.01 EPS for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.05, Yahoo Finance reports. The business had revenue of $356.26 million for the quarter, compared to analysts’ expectations of $338.70 million. Clover Health Investments had a negative net margin of 8.63% and a negative return on equity of 48.07%. During the same period in the previous year, the company posted ($0.06) earnings per share.

Clover Health Investments Trading Down 0.3 %

NASDAQ:CLOV traded down $0.01 on Wednesday, reaching $1.83. The stock had a trading volume of 429,792 shares, compared to its average volume of 7,403,094. Clover Health Investments has a 12-month low of $0.61 and a 12-month high of $2.01. The stock has a market cap of $906.00 million, a P/E ratio of -5.38 and a beta of 2.10. The company has a 50-day moving average of $1.37 and a 200 day moving average of $1.03.

Clover Health Investments Company Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.